Drug Database
Back to search

Belgium· BE-AMP-SAM440237-00

Tachipri Hyperbar 20 mg/ml

A prilocaine product containing prilocaine hydrochloride, registered in Belgium by Nordic Group. The same ATC class is registered in 14 of our 19 countries.

ATC N01BB04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTachipri Hyperbar 20 mg/mlATCN01BB04REGISTER NO.BE-AMP-SAM440237-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about prilocaine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Prilocaine is registered in 14 of 19 countries.

Countries holding a registration under ATC N01BB04 (prilocaine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search prilocaine products by name

Prilocaine · ATC N01BB04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Prilocaine Hydrochloride
Manufacturer
Nordic Group
Country
Belgium (BE)
ATC code
N01BB04
ATC class
Prilocaine
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3157278

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

39 interactions on record for prilocaine.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check prilocaine against other medicinesHow interaction checks work

Prilocaine · interactions on record

39 records

  • 36 severe
  • 2 moderate
  • 1 minor

Most severe, free to view

  • LidocainA01AE01severe
  • TetracainA01AE02severe
  • MetoclopramideA03FA01severe
  • SulfasalazineA07EC01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Prilocaine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prilocaine products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Takipril Hyperbar
  • Bulgaria · Такиприл
  • Germany · Takipril, Xylonest
  • Denmark · Takipril
  • Spain · Takipril Hiperbárica
  • Finland · Takipril
  • France · Baritekal
  • United Kingdom (Northern Ireland) · Prilocaine Hydrochloride, Prilotekal
  • Hungary · Prilotekal
  • Italy · Prilotekal
  • Luxembourg · Citanest, Citanest 1%
  • Netherlands · Citanest 1 %, Citanest 2 %
  • Norway · Takipril
  • Poland · Prilotekal
  • Sweden · Citanest, Takipril
  • Slovakia · Prilotekal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f92ab326-dae0-4e3c-a7cb-30b42c229b60
GET /v1/drugs/f92ab326-dae0-4e3c-a7cb-30b42c229b60?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tachipri Hyperbar 20 mg/ml",
  "name_fr": "Tachipri Hyperbar 20 mg/ml",
  "name_nl": "Tachipri Hyperbar 20 mg/ml",
  "amp_code": "SAM440237-00",
  "strengths": [
    "20.0000",
    "60.0000",
    "0.3900"
  ],
  "pack_count": 1,
  "substances": [
    "Prilocaine Hydrochloride",
    "Glucose",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Prilocaine",
  "authorisation_numbers": [
    "BE440237"
  ]
}
API referenceMCP serverPlans

See everything about prilocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console